Background: The link between parasitic infections and either allergic diseases or unexplained neurologic manifestations was hypothesized especially in children. However, the debate continues regarding this link. Aim of the work: To determine the seroprevalence of toxocariasis in children with different allergic diseases [bronchial asthma and skin allergy], besides the unexplained neurological manifestations [epilepsy and focal neurologic deficits] in children. Patients and methods: Children with bronchial asthma [40 children], skin allergy [40 children], and unexplained neurological manifestations [epilepsy and focal neurologic deficits], [40 children] were included. All underwent a full history taking, clinical examination, lab investigations and determination of seropositivity for Toxocara canis. Results: Eosinophilia was reported in 22.5%, 30.0% and 17.5% of asthma, skin and unexplained neurological manifestations groups respectively. In patients with asthma, the prevalence of toxocariasis was 15.0%, in skin disease, the incidence was 7.5% and in unexplained neurological manifestations, it was 12.5%. There was no significant difference between positive and negative toxocariasis in regard to patient demographics. But there was a significant increase in contact with pets, chronic urticaria, lymph nodes involvement and eosinophilia in positive when compared to negative groups. Conclusion: The association between Toxocara canis infection and allergic diseases such as bronchial asthma, chronic urticaria and unexplained neurological manifestations [epilepsy and focal neurologic deficits], was confirmed in the present work. The contact with dogs and cats [pets] was the major determinant risk factor explaining such association. Prospective cohort studies were warranted to examine the cause effect relationship.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.